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ABSTRACT 
 
 The Sec 61 complex in eukaryotes is a passive pore in the endoplasmic reticulum 
(ER) membrane that permits a secretory protein to enter the ER membrane or lumen.  To 
facilitate understanding of channel opening and closing, and especially to help determine 
the location of the plug domain relative to key cysteine residues, several yeast Sec 61 
mutants were constructed by site-directed mutagenesis of cysteine residues at positions 
C121, C150, and C373.  The mutants expressed Sec 61 and showed growth defect 
phenotypes. 
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BACKGROUND 
 
Protein Secretion 
Protein secretion, the process whereby proteins are assembled into membranes or 
secreted into the matrix, has long been of interest to researchers (Rapoport, 2007).  This 
process results from the interaction of two major organelles, the endoplasmic reticulum 
(ER) and Golgi apparatus, transporting materials via vesicles.  Early work on secretion 
includes the finding of George Palade that secretory proteins cross the ER membrane 
before being transported to the plasma membrane at the cell surface via vesicles (Palade, 
1975).  And in 1975, Gunter Blobel suggested that the aqueous TM channel helps 
mediate protein transport through the rough ER (RER) membrane (Blobel and Sabatini, 
1971).  Blobel later determined that secretory proteins contain an N-terminal signal 
sequence that directs the translocation of secretory proteins across the RER membrane 
(Blobel and Dobberstein, 1975).  
 
Endoplasmic Reticulum 
The ER is the largest organelle in eukaryotes (by volume), and functions in a 
variety of biosynthetic reactions, including the synthesis of secretory proteins, calcium 
ion storage, membrane integrations, synthesis of steroids and phospholipids, and post-
translational protein folding and modification (Matlack et al., 1998). The ER membrane 
initially forms from the nuclear envelope, and extends throughout the entire cytoplasm.  
It is a single membrane organelle containing a continuous intraluminal space. The ER is 
divided into the rough ER (RER) (named after the rough granulated appearance due to 
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the presence of membrane-bound ribosomes), and the smooth ER (SER), and the lumenal 
flow is from the RER to the SER (Voeltz et al., 2002).  
The RER is the site of secretory protein synthesis and membrane integration.  
Protein translocation occurs primarily in this region of the ER. The SER has different 
functions depending on the cell type, and is found in all cells involved in packaging 
proteins for export to the Golgi. SER functions include calcium ion storage and secretion 
in muscle, production of steroid and phospholipids, or detoxification of hydrophobic 
substances, depending on the cell type (Voeltz et al., 2002). 
 
ER Translocation Channel 
Most proteins are transported through the ER membrane by a translocation 
channel (Rapoport, 2007).  The translocation channel was discovered by genomic 
mutation screening, electrophysiology, and florescence quenching experiments (Menetret 
et al., 2000).  The channel is formed from a conserved heterotrimeric protein complex 
(Figure-1) whose channel allows the transfer of the secretory polypeptide chain across, 
or integration into, the ER membrane.  Targeting to the channel is facilitated by the 
presence of the N-terminal hydrophobic signal sequence and its bound signal recognition 
particle. Removal of the signal sequence by signal peptidase in the ER membrane 
reinitiates protein synthesis in the ER lumen.  For membrane proteins, once their 
hydrophobic transmembrane domains are synthesized, they enter the ER membrane 
through an opening in the channel, and are released into the lipid phase (Van den Berg et 
al., 2004). 
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Figure-1: Structure of the ER Translocation Channel.   A, Stereo view 
from cytosolic view of the structure. The numbers represent the trans-
membrane segment number. The red to blue helix is the -subunit, the -
subunit is pink, and the -subunit is magenta. B The back of the structure 
with the phospholipid head group and hydrocarbon regions of the 
membrane shown in blue and grey in the background. Cytosolic loops are 
indicated in the structure. C Top view with the N- and C-terminal halves 
of the -subunit in blue and red, respectively. D The top view of the 
membrane. E Slab views of the structure. The foreground are removed 
with TM1 in dark blue, TM2a and TM2b in sky blue. (Van den Berg et al., 
2004).  
 
 
The ER translocation channel is formed from a conserved heterotrimeric 
membrane complex, either Sec61 (in eukaryotes) or SecY (in bacteria and archaea). The 
α-subunit is the largest subunit of this channel, consisting of 10 transmembrane domains, 
with its N- and C-termini in the cytosol.  The β-subunit in eukaryotes and archaea spans 
the membrane once, while in eubacteria it spans the membrane twice.  The γ- subunit 
spans the membrane once (Osborne et al., 2005). Genetic knock out experiments 
performed in S. cerevisiae and E. coli have shown that both the α and γ subunits are 
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required for cell viability. The α- subunit forms the pore of the channel, and contains the 
docking site for the signal sequence (Van den Berg et al., 2004).  The Sec 61 channel is a 
passive pore that allows polypeptides to enter the ER lumen. The channel needs cytosolic 
partners for translocation to occur, and based on the type of partner there are three 
different modes of translocation: two modes in post-translational translocation, and one in 
co-translational translocation (Rapoport, 2007). 
 
Co-Translational Translocation 
The ribosome is the primary partner involved in protein co-translational translocation, 
found in all cells.  This mode of translocation is used for some types of secretory proteins 
and for the synthesis of integral membrane proteins (Figure-2) (Rapoport, 2007). 
 
Figure-2: Diagram of Co-Translational Translocation.  In this process, a 
ribosome initially synthesizes a portion of the secretory protein containing the 
signal sequence.  Signal recognition particle (SRP) binds the signal sequence 
halting translation.  The SRP then binds the SRP receptor in the ER membrane 
docking the ribosome.  The ribosome then associates with the Sec61 complex, 
which helps cleave the signal sequence to resume translation of the secretory 
protein and its release in the ER lumen (Rapoport, 2007) 
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This process begins in the targeting phase, where the cytoplasmic signal 
recognition particle (SRP) recognizes the transmembrane span or signal sequence of a 
growing secretory polypeptide chain, temporarily halting its translation. The complex 
containing the ribosome, mRNA, and SRP is then targeted to the ER membrane when the 
SRP and ER SRP-receptor interact. This docking leads to interaction between the 
ribosome and the translocation channel (Rapoport, 2007). Translation resumes, and the 
protein can enter the lumen or the membrane.  Although the movement of the polypeptide 
in the channel is independent of nucleotide hydrolysis, movement to the membrane is 
mediated by GTP hydrolysis (Osborne et al., 2005).  
 
Post-Translational Translocation 
 The second type of translocation, post-translational translocation, occurs when 
proteins are transported after synthesis (Figure-3).  In yeast, about 60% of proteins are 
translocated by this mechanism. Yeast and bacteria often use this pathway because of 
different paces of translation and translocation (Rapoport, 2007). 
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Figure-3: Diagram of Post-Translational Translocation in Eukaryotes.   This 
process is similar to the previous diagram, except the secretory or membrane 
protein arrives at the RR membrane already synthesized.  (Rapoport,2007) 
 
 
 In yeast and most eukaryotes, this process begins by the binding of cytoplasmic 
chaperones, such as HSP70, to the fully synthesized secretory or membrane protein.  
Then this complex docks with the ER tetrameric Sec62/63 complex in the ER membrane, 
and the protein is released from the cytosolic chaperons. After the polypeptide is inserted 
into the channel, a ratcheting mechanism causes translocation and prevents the protein 
from sliding back and forth by Brownian motion. Binding to the BiP inside the lumen of 
the ER prevents the polypeptide from moving back into the cytosol. Closing of the Sec61 
peptide-binding pocket around the peptide occurs when ATP-bound BiP interacts with 
the J-domain of Sec 63.BiP activated by the J-domain interacts with any polypeptide 
segment that appears from the channel into the lumen. The process continues until the 
polypeptide chain has navigated into the channel. In the final stage, ATP is hydrolyzed, 
and the peptide-binding pocket opens and releases BiP (Rapoport, 2007). 
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In bacteria, post-translational translocation involves the Sec Y channel and the 
cytosolic ATPase SecA, and this applies to most of the secretory proteins (Figure-4). Sec 
A contains several domains, including two nucleotide binding folds (NBF).  After the Sec 
Y undergoes a conformational change with the ATPase, the polypeptide is pushed 
through the channel (Osborne et al., 2005). 
 
 
Figure: 4: Diagram of Post-Translational Translocation in Bacteria.  This 
process is similar to that described for eukaryotes, except the translocation 
channel is Sec Y, and the ATPase is located in the cytoplasm.  (Rapoport,2007) 
 
 
Open State of the Channel 
 
 The translocation channel must be in the open state for secretory proteins to 
transport across the membrane (Matlack et al., 1998). Channel opening involves two 
steps, starting with the binding of the channel to a partner used in either mode of 
translocation.  Prior to ribosome binding, a plug occurs in the center of the channel. 
Ribosome binding occurs with a cytosolic loop in the carboxyl half of the channel, 
causing a temporary displacement of the plug domain, and a continuous opening and 
closing of the lateral gate (Rappaport, 2007). 
 12 
The second step involves the hydrophobic segment of a signal sequence entering 
the lateral gate.  Experiments have shown that creating a defective signal sequence can 
destabilize the closed channel (Rapoport, 2007).  Further information about how the 
channel opens have also been proved by analysis of channel structures, biochemical 
characterization of translocation intermediates, molecular dynamics simulations, and in 
vivo and in vitro analysis of structure-based Sec61 and SecY channel mutants. 
 In mammals, the ribosome binding site on Sec61 was mapped to Loop 6 and Loop 
8, both of which are exposed cytoplasmically. Upon binding, the channel undergoes a 
conformational change, so the signal sequence is inserted into the sequence-binding 
(SSB) site (Zimmer et al., 2008).Three structures with different SecY lateral gate 
domains have been characterized from M. jannaschii, T. thermophilus, and T. martima, 
and have shown the partial open state of the channel (Figure-5).  The structure of the 
plug domain in M. jannaschii opens in the front of the lateral gate with two α subunits. 
The crystal structure of this plug domain shows an L shaped structure, with the tip of the 
loop parallel to the membrane surface. Comparing to loop 6, loop 8 is closer to the 
membrane bilayer. The closed conformational shape of T. thermophiles SecY-E is similar 
to the M. jannaschii SecY-E beta structure.  The binding of anFab antibody to the tip of 
loop8 causes a separation of the cytosolic end of the lateral gate.  For the T. maritime 
plug domain, Sec YEG –Sec A complex has a conformational change when adding a 
non-hydrolysable ATP analog. The binding of SecYEG and SecA results in separation of 
the cytosolic and exofacial portion of the SecY lateral gate (Mandon et al.,  2009). 
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Figure 5: Diagram of Three Known Structures of the Sec Y Lateral Gate 
Domain.  Shown are the known structures for the lateral gate domain of (a) M. 
jannaschii ; (b), T. thermophilus ; and (c) T. maritima. (Mandon et al.,  2009). 
  
 
 Membrane barriers for ions and small molecules are maintained in the SecY 
complex during protein translocation. For the closed state of the channel, a binding 
partner is not needed for the SecY molecule. The plug domain and pore ring work 
together keeping the channel closed for small molecules. Mutating the pore ring could 
affect interactions that keep the plug in the center of the molecule, and moving the plug 
could change the size of the pore ring.  In previous experiments, modifying the cysteine 
residue in the plug and the pore ring caused the channel to open transiently for the SecY 
complex. With disulfide bridge formation, the plug was moved out and the channel 
opened permanently.  Similar experiments have not yet been performed for eukaryotic 
Sec61.  The Sec61 complex in eukaryotes is similar to SecY by sequence conservation 
(Saparvo et al., 2007).  
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PROJECT PURPOSE 
 
 To further understand how the ER Sec61 protein-conducting channel opens 
during protein translocation, new channel structures must be analyzed, including 
translocation intermediates, and in vivo and in vitro synthesized Sec61 mutants.  For this 
project, novel Sec61 mutants were designed based on the known structure of the 
homologous M. janaschii SecYEb complex. The full open state for the molecule is 
unknown. A possible disulfide bond could be formed between a cysteine residue in the 
plug helix and the periplasmic tail of SecE, but it is unknown whether this cysteine 
residue is accessible for bond formation in the open state of the channel (Mandon et al., 
2009).  The purpose of this project was to design and synthesize various SecYEb channel 
domains and mutants to help investigate the molecular mechanisms of channel opening.  
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METHODS  
 
 
 
Plasmid Cloning 
 
Sec61 Mutagenesis and PCR 
Four different yeast Sec61 mutants were created by PCR site-directed 
mutagenesis by other personnel in our laboratory.  The four mutants created are listed in a 
Table at the beginning of the Results section. 
 
Purification of PCR Product 
Sec61 PCR amplicons were purified from agarose gels using the QIAquick Gel 
Extraction kit (Qiagen).  Each amplicon band in an agarose slice was mixed with 850 µl 
of the provided QG buffer, and incubated at 55ºC for 15 minutes. Then 250 µl of ethanol 
was added to each sample and mixed. The sample was transferred to a 2ml collection 
tube, and centrifuged for 1 minute to pellet the DNA bound to beads. The pellets were 
washed with 750 µl of Buffer PE, then microcentrifuged for 1 minute. The DNA was 
eluted from the beads using 43 µl of sterile dH2O.  
 
Restriction Digestion of Amplicon Bands and Plasmids 
 Purified amplicon and plasmid DNAs were digested with HindIII according to the 
following Table: 
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Component 
Amplicon 
Digestion 
Plasmid 
Digestion 
10X Buffer-2 4 μl 2 μl 
BSA 0.4 μl 0.2 μl  
HindIII 2.0 μl 1.0 μl 
Sterile dH2O  10.8 μl 
Amplicon DNA 33.6 μl  
Plasmid DNA pRS316  6.0 μl 
Total Reaction Volume 40 μl 20 μl 
 
The reactions were incubated for 2 hours at 37ºC, then 0.5 µl of calf intestinal 
phosphatase (CIP) was added  to the plasmid reaction (to dephosphorylate the 5’ end to 
help prevent self-ligation)and the reaction was incubated for an additional 30 minutes at 
37ºC.  Without inactivating either enzyme, the reactions were directly electrophoresed on  
agarose gels to determine how much of the Amplicon and plasmid to add to the ligation 
mix. 
DNA Ligations 
 DNA ligations were set up according to the following: 
Ligation 
Amplicon 
Digestion 
Amplicon HindIII Digestion x- μl 
Plasmid HindIII Digestion x- μl 
T4 DNA Ligase 2.0 μl 
Sterile dH2O x- μl 
10X T4 Ligase Buffer 2 μl 
Total Reaction Volume 20 µl 
 
 
The tubes were incubated at 16ºC overnight, using a thermocycler. 
 
 
DNA Transformation into E. coli 
 
Following ligation, 3 μl of the ligation reaction was added to a separate centrifuge 
tube with 60 μl of thawed competent E. coli cells previously made competent by lab 
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personnel. These tubes were incubated on ice for 25 minutes, and were then placed into a 
42˚C water bath for 30 seconds.  Next, the cells were again incubated on ice for two 
minutes before 500 μl of LB media was added. Then, the cells were incubated at 37˚C or 
one hour.  Following this incubation, 350 μl were spread on an LB-Ampicillin plate and 
incubated at 37˚C overnight. 
 
 
 
Colony PCR 
 
 If E. coli colonies grew after the transformation, ~ 20 different colonies were 
randomly selected, picked with a toothpick, and mixed with 25 μl sterile water to make a 
suspension that was used as template. Each toothpick was placed in LB- Ampicillin 
media and grown overnight at 37°C. Each colony PCR reaction contained the following: 
 
PCR reaction Amount 
Sterile dH2O 14 μl 
10 X Taq Buffer 2.5  μl 
dNTP 2.5 μl 
Taq Polymerase  1 μl 
Sec61 Forward Primer  1.25 μl 
Sec61 Reverse Primer 1.25 µl 
Template 2.5 µl 
Total Reaction Volume 25 µl 
 
The tubes were microcentrifuged, then mineral oil was added to each reaction, and the 
tubes were placed in a thermocycler, and run as following: 
  
PCR Program Temperature 
Time 
(Minutes) 
Denaturation 95 ºC 5 
Denaturation 94ºC          0.5 
Anneal 50 ºC          0.5 
Extension 72 ºC          2.5 
Repeat Step 2-4  30 times 
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 72 ºC 5 
 
4 ºC 
At least 10 
minutes 
 
 
 
Plasmid DNA Isolation 
 
Plasmid DNA was isolated from overnight E. coli cultures using a QIA Prep Spin 
MiniPrep Kit (Qiagen). DNA pellets were resuspended in Buffer P1, then 250 ul of 
Buffer P2 was added to the resuspension and mixed. Then 350 ul of Buffer N3 was 
added, and the mixture was centrifuged for 10 minutes. The supernatant was transferred 
to a QIA prep spin column, centrifuged for 60 seconds, then 0.75 mL of ethanol 
containing Buffer PE was added.  The column was centrifuged for 1 minute, and the flow 
through was discarded.  The spin column was centrifuged for an addition minute, then the 
DNA was eluted with 50 ul of sterile water.  
 
Plasmid Transformation into Yeast 
 
 Yeast cultures (WT strain V5) were grown in yeast medium +SSH and -SHH 
overnight at 30ºC, then plasmid DNA was isolated using a LiAc Method (lab TRAFO 
Solution Page) with two adjustment: the SS-DNA was not boiled, and the transformation 
mix consisted of the following instead of the amount stated in the procedure: 
Transformation Mix Amount (μl) 
PEG (50% w/v) 240 
1.0 M LiAc 36 
ss-DNA 8 
Plasmid 2 
Sterile dH2O  74 
Total Reaction Volume 360 
 
The mixture was added in the order listed in the table. After two 30 min incubations, one 
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at 30ºC then one at 42 ºC, the reactions were micocentrifuged for 15 seconds. The cell 
pellet was resuspended in 500 μl of sterile water instead of 1 ml, then plated on SD-AUT 
plates and incubated at 30ºC for two days.     
 
Yeast Dilution Growth Assays 
 
 Sec61 plasmid containing yeast were grown overnight to an ideal optical density 
of less than 1 OD at 600 nM.  Cell suspensions were diluted to 0.1 OD for a 50 ul sample, 
and then four 1:10 serial dilutions were prepared.  5 ul of the four diluted samples were 
plated on 2 YPD plates, then the plates were incubated one at 30ºC and one at 37ºC for 
two days.  
 
Preparation of Yeast Whole Cell Lysates 
 
 Yeast cultures were grown overnight at 30ºC in 4 ml of YPD media. The cells 
were pelleted and resuspended in 200 μl of TCA Buffer.  ~300 mg of glass beads was 
added to the tubes, then the tubes were vortexed six times for 30 seconds and put on ice 
for 30 seconds after each interval. The supernatant was transferred to a new tube, and the 
beads were washed 2 times with 100 μl of TCA Buffer.  The supernatants were combined 
and centrifuged at 4ºC for 5 minutes.  The pellets were resuspended in 200 μl of 
resuspension buffer, then incubated at 55ºC for 25 minutes. 
 
Protein Quantification 
Proteins were quantified using the Bradford Assay.  A standard curve was 
generated using BioRad Reagent A and B with the following amounts of BSA in each 
tube:  0, 1 μl, 2 μl, 4 μl, and 6 μl. For each protein sample 2.5 μl was added to 22.5 μl of 
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water, then the BioRad reagent was added to each tube and incubated at room 
temperature for 15 minutes. The OD was taken at 750 nm. 
 
Sec61 Western Blots 
 
Protein samples were electrophoresed on 10% SDS-PAGE overnight at 6 volts, 
then transferred to membrane. The primary antibodies V5 and PGK were monoclonal 
purchased from Invitrogen, used at a dilution of 1:5000. The secondary antibody was 
anti-mouse IgG purchased from Pierce used at a dilution of 1:10000.  Sec61 antibody was 
a gift to the lab, used at 1:5000.  The secondary used for that antibody was anti-rabbit 
IgG purchased from Pierce and used at of 1:10000. 
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RESULTS 
 
 
Yeast Sec61 Mutagenesis 
 To facilitate our understanding of the accessibility of substrates to the Yeast Sec61 
translocation channel plug region, yeast cells carrying mutated forms of Sec61 plasmids 
were constructed and analyzed.  The Sec61 positions selected for mutagenesis (see Table 
below) were based on the position of 3 key cysteine residues at positions 121, 150, and 
373.  All three cysteine residues were mutated for strains 170 and 172. The mutated 
I320C position in three of the strains is expected to provide ideal conditions for labeling 
with water soluble maleimide with or without the presence of ribosome. M69 and S72 
(present in 170 and 172) are both in the plug domain area.  Strain 138 was a control, 
mutated at unrelated sites. 
Mutant 
Designation 
Sec61 Residues Mutated 
138 I86T, Q308A, I323A W326A, and L342A 
pEM707 I320C 
170 C121A, C150A, I320C, C373A, and M69C 
172 C121A, C150A, I320C, C373A, and S72C 
 
The first stage of this multi-step project involved constructing the four mutant 
Sec61 genes in plasmid DNAs, and confirming the presence of the mutation in the Sec61 
gene.  The mutants were created by site-directed mutagenesis of recombinant plasmids of 
the Sec61 gene by other personnel in the lab.  Following PCR with mutated primers, the 
purified amplicons were digested with HindIII and ligated into similarly digested plasmid 
pRS316.  Following transformation into yeast, colony PCR (Figure-6) was used to screen 
for positive clones containing the mutant of interest.   
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Figure-6: Example Gel for a Colony PCR.  Shown is the colony 
PCR for clone pEM707.  Lane 7 is positive.  
 
Plasmid DNA was isolated from positive colonies, and mutations were confirmed 
by DNA sequencing.  Mutated Sec61 plasmids were then transformed into yeast by using 
the LEU2 gene for selection by plating onto plates containing 5-fluroroorotic acid (5-
FOA).  If colonies are positive, URA3 gets shuttled out.  
 
Effect of Sec61 Mutations on Growth 
The potential difference in growth rates of the four prepared yeast Sec61 mutants 
were examined by plating serial dilution of cells onto YPD plates.  In this experiment, 
positive and negative controls for each strain were based on the observation that Ssh1p is 
nonessential and its expression cannot suppress a null mutant. The control had an amino 
acid substitution at position R275 causing a growth defect in the absence of Ssh, but not 
in the presence of Ssh.  
The first strain tested in growth experiments was pEM707, which had an amino 
acid substitution at I320C.  Figure-7 compares the growth of pEM707 with and without 
+    -     -     -    -    -      -     +     -     -      - 
+    1    2    3    4   5     6     7     8    9    10 
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SSH relative to control strain R275.  The data confirmed there is a growth defect in 
pEM707 at either temperature. This mutant showed less growth without SSH (rows 5 and 
6) compared to the presence SSH (rows 3 and 4) where more growth occurred.  In the 
presence of SSH, pEM 707 showed a growth rate similar to R275.  In the absence of 
SSH, pEM 707 showed less growth compared to WT, especially on the 37°C plate.  
             30 °C                   37°C 
     
  
Figure-7: Growth Analysis of Sec61 Mutant pEM 707.  pEM707 is mutated in 
Sec61 at I320C.  Left panel was incubated at 30°C, and the right panel incubated at 
37°C for 2 days.  R275 was the wild-type control. 
 
 
In Figure-8, mutant 138 containing Sec61 mutations at I86T, Q308A, I323A 
W326A, and L342A, was compared to R275 WT control.  This strain also showed small 
growth defects relative to WT.  In the absence of SSH (rows 5 and 6), the colonies were 
slightly smaller than the colonies in the presence of SSH (rows 3 and 4).   
  
R275 101  +SSH 
 
R275  102  -SSH 
 
pEM 707 +SSH #1  
 
pEM 707 +SSH #2 
 
pEM 707 -SSH #1 
 
pEM 707 -SSH #2 
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30 °C       37°C 
     
 
Figure-8: Growth Analysis of Sec61 Mutant 138.  This mutant contains amino acid 
changes at I86T, Q308A, I323A W326A, and L342A. Left panel was incubated at 
30°C and the right panel at 37°C for 2 days.  R275 was the wild-type control. 
 
 
Figure-9 shows the growth analysis of mutant 170, containing amino acid 
substitutions at C121A, C150A, I320C, C373A, and M69C. This mutant appears to show 
less growth in the presence of SSH (rows 5 and 6) relative to without SSH (rows 3 and 
4).   
30 °C       37°C 
      
 
Figure-9: Growth Analysis of Sec61 Mutant 170.  This mutant shows altered 
amino acids at positions C121A, C150A, I320C, C373A, and  M69C. The left panel 
was incubated at 30°C and the right at 37°C for 2 days.   Upper two rows contains 
R275 wild-type control. 
 
 
 
 
R275 101  +SSH 
 
R275  102  -SSH 
 
138 +SSH #1   
 
138 +SSH#2 
 
138 -SSH #1 
 
138 -SSH #2 
R275 101  +SSH 
 
R275  102  -SSH 
 
170 -SSH #1   
 
170 -SSH#2 
 
170 +SSH #1 
 
170 +SSH #2 
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Figure-10 shows the growth analysis of mutant 172 with amino acid substitutions 
at C121A, C150A, I320C, C373A, and S72C.  This mutant appears to show a growth 
defect relative to WT.  
30 °C       37°C 
      
 
Figure-10: Growth Analysis of Sec61 Mutant 172.  This mutant contains altered 
amino acids at positions C121A, C150A, I320C, C373A, and  S72C. Left panel was 
incubated at 30°C and the right at 37°C for 2 days.  Upper two rows shows WT strain 
R275 used as control. 
 
Immunoblots to Verify Sec61 Expression 
After confirming that some of the constructed mutants showed growth defects, 
Sec61 western blots were used to assay the cellular levels of the Sec61 protein.  Whole 
cell lysates were prepared from the four mutant strains and the R275 positive control, 
loaded onto 10% SDS-PAGE gels, blotted to membrane, then analyzed with Sec61 and 
PGK antibodies. The upper band on each blot represents PGK, the middle band is full 
length V5 Sec61, and the lower band is mutant Sec61.  The absence of V5 indicates 
whether WT Sec61 was successfully shuttled out of each mutant strain.  PGK was used to 
detect an unrelated protein to determine whether non-target protein levels were affected 
by the Sec61 mutants.  The immunoblots (Figures 10, 11, and 12) show that for WT 
strain R275, the absence of SSH lowered the level of Sec61 protein in one trial (Figure-
R275 101  +SSH 
 
R275  102  -SSH 
 
172 +SSH #1   
 
172 +SSH#2 
 
172 -SSH #1 
 
172 -SSH #2 
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11) but increased it in a different trial (Figure-13).  None of the mutant strains showed 
bands for V5, indicating that WT Sec61 (under the control of URA3) had been 
successfully shuttled out of those strains, and had been replaced with the mutant Sec61 
(under the control of LEU2).  Mutant 170 (Figure-11) showed a decrease in expression 
compared to WT containing Ssh in the same trial, but for this mutant with and without 
the presence of Ssh Sec61 was expressed at similar level. Comparing to WT without no 
Ssh this mutant had higher expression level.  For mutant 172 ( Figure-12), the expression 
level was higher in the presence of Ssh compared to without Ssh. This mutant closely 
resembles the WT expression in Figure 11.  Mutants 138 and pEM 707 (Figure-13), both 
showed lower Sec61 levels with Ssh compared to without Ssh.  Both of the mutants 
showed lower Sec61 level compared to WT containing Ssh. Without the presence of Ssh 
the Sec61 level was higher for 138 and the expression for pEM707 lower compared to 
WT.  The purpose of these immunoblot was to show whether these mutant Sec61 are 
generally expressed in the yeast cells. 
 
 
Figure-11: Western Blot Analysis of  
Mutant 170. 
 
 
 
 R275      R275   170     170    170       V5        
+SSH     -SSH   +SSH   +SSH -SSH 
V5 
           PGK 
           Sec61 
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Figure-12: Western Blot Analysis  
of Mutant 172.  
 
 
 
   
  
Figure-13: Western Blot Analysis of Mutants 138 and pEM707.  
 
 
 
Due to time constraints, the accessibility of various substrates to the plug region 
of each Sec61 mutant was not determined.  However, the overall results show that each 
mutant was successfully constructed and produced Sec61 protein which can be analyzed 
in the future. 
  
 V5         172             172      172     
              +SSH          -SSH     -SSH      
           PGK 
           V5 
           Sec61 
  R275  R275  138     138    138  138     pEM707  PEM 707  
+SSH  -SSH  +SSH +SSH -SSH –SSH +SSH  +SSH  -SSH –SSH  
           PGK 
           Sec61 
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DISCUSSION 
   
 In order to increase our understanding of the molecular mechanisms of Sec61 ER 
translocation channel opening, various Sec61 mutants were constructed.  Successful 
mutagenesis was verified by sequence analysis, and Western blots demonstrated that each 
mutant expressed Sec61 protein.  The mutants will be used in the future to determine the 
accessibility various substrates to the plug region.  
The sites chosen for mutagenesis included cysteine residues at C121, C150, and 
C373, because these may be key residues important for accessibility in the plug region.  
Residue I320 was mutated because it is expected to allow subsequent labeling with 
maleimide with or without ribosome for future experiments. Sites M69 and S72 are at the 
pore region of the complex. The dilution assays of the four mutants showed growth 
defects, so these mutants could alter protein translocation. Comparing the mutants, 170 
and 172 showed more effects on yeast growth, so the mutated cysteine residues, I320, and 
the residues in the pore region together could alter protein translocation. 
The immunoblots confirmed the expression of Sec61 protein in each strain, and 
also showed that none of the mutant strains produced Sec61 V5 indicating the URA3-
marked Sec61 plasmid was successfully shuffled out and was only expressing the LEU2-
marked mutant Sec61.  
 Many problems were encountered in this project.  A major problem occurring 
many times was a lack of any positive clones following transformation of ligated 
plasmid.  Since most screened plasmids were negatives, the calf intestinal phosphatase 
procedure used to dephosphorylate the 5’ ends of the vector may have been inefficient, 
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allowing self-ligation without insert.  In addition, one positive clone was lost after 
confirming the presence of insert with HindIII digestion, perhaps due to poor mini-preps 
and contamination.  For the yeast transformations, on several occasions no colonies grew, 
possibly due to the presence of WT plasmid which does not allow growth on the selection 
plates. 
Overall, the mutant strains created in this project will allow follow up assays to be 
performed to determine whether the mutants affect protein translocation, to determine 
whether Sec61 is in an open state conformation, and to determine the accessibility of 
substrates to the plug region.  This represents the first step to our lab’s long term goal of 
understanding the molecular mechanisms of translocation channel opening. 
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